ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 120 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $188,773 | -94.0% | 11,978 | -92.3% | 0.00% | -94.8% |
| Q3 2023 | $3,138,889 | -26.9% | 156,475 | +2.7% | 0.08% | -23.0% |
| Q2 2023 | $4,296,298 | +0.5% | 152,297 | -38.7% | 0.10% | -20.6% |
| Q1 2023 | $4,273,168 | -9.6% | 248,440 | +5.9% | 0.13% | -5.3% |
| Q4 2022 | $4,724,985 | -10.2% | 234,607 | -3.5% | 0.13% | -14.2% |
| Q3 2022 | $5,263,000 | +54.0% | 243,003 | +99.8% | 0.16% | +61.5% |
| Q2 2022 | $3,417,000 | – | 121,595 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |